click the image for full view.
Showing posts with label Diseases. Show all posts
Showing posts with label Diseases. Show all posts
Sunday, 29 November 2009
More people die by fire than swine flu
oh yes, it is true. 300 days, the 300th day being 17th November 2009.
click the image for full view.
click the image for full view.
Friday, 27 November 2009
Scientific paper points to possible laboratory origin of swine flu
A team of scientists led by Dr. Adrian Gibbs of Australia publish their theory that the swine flu emerged from a laboratory.
::::::::
Dr. Adrian Gibbs, Australian Virologist, on Bloomberg TV
PETER'S NEW YORK, Tuesday, November 24, 2009--A just-released scientific paper spells out the hypothesis, first suggested in the weeks following the initial outbreak of swine flu in humans in the Spring of 2009, that the flu emerged from a laboratory.
The peer-reviewed paper, published today in the Journal of Virology, analyzes the makeup of the genes of the now-famous A H1N1 virus, and concludes that, although it could possibly have come about through cross-contamination among flocks of birds or herds of swine, an equally, or perhaps more probable explanation is that it emerged from laboratories that store viruses for research or vaccine production.
The authors, Adrian J. Gibbs, John S. Armstrong and Jean C. Downie, contend they have identified three swine flu viruses as the most likely parents of the new flu. The last time these parent viruses were known to have caused disease in pigs was from ten to seventeen years ago. Each parent comes from a different continent--one from North America, another from Europe, and a third from Asia. In order for these parent viruses to have combined in nature to form the new virus, pigs would need to have breached strict quarantines designed to prevent the spread of livestock disease. But the scientists note that the European parent was never found in North America, nor the North American virus in Europe, indicating that the quarantines were effective. This, of course, begs the question of how the parent viruses got together to form the new virus.
Some scientists have suggested that the pigs were shipped internationally and violated the strict quarantines. But Gibbs and his colleagues say perhaps a more credible hypothesis is that the parent viruses were individually stored in different sections of a laboratory, or in different laboratories, and were brought together for research or in the production of a vaccine. Storage in a laboratory would also explain why the parent viruses remained undetected in pig populations for a decade or more, and then suddenly emerged as components of the new virus--they were sitting on a shelf in a laboratory refrigerator during the interim. "Viruses," the paper notes, "do travel between laboratories in cells." The authors say additional investigative work is needed to establish which scenario is most likely.
"The possibility that human activity may have had some role in its (the swine flu virus) origins should not be dismissed without a dispassionate analysis of all available evidence," the paper states.
The escape of a disease-causing virus from a laboratory would not be an unprecedented event, the authors contend. They note that a virus that had not been sampled since the 1950s and one that emerged in 1977 were practically identical. Had the virus been infecting humans in the interim, it would have mutated. The absence of mutations suggests that the virus had been sitting in a laboratory refrigerator during the time its presence in humans went undetected.
The best ways to trace the origins of the new swine flu, according to Gibbs's team, is by maintaining a database of viruses and viral components from laboratories around the world, and by instituting more intense monitoring of infected animal and human populations.
The swine flu virus "has already proved to be a significant and very costly cause of mortality and morbidity in the human population," the authors note. "It is important that the source of the new virus be found if we wish to avoid future pandemics rather than just trying to minimize the consequences after they have emerged."
Gibbs, lead author of the paper, achieved notoriety in May of 2009 when he was among the first in the scientific community to suggest that the virus causing the swine flu showed telltale signs of having been produced in a laboratory. Gibbs, who has some 200 scientific publications to his credit, became a familiar icon on TV screens across the globe after being interviewed about his theory by reporters and talking heads from major media outlets. The Australian professor and researcher relayed his concerns to officials at the Geneva-Switzerland-based World Health Organization (WHO), where scientists examined, but tentatively rejected, his hypothesis. A WHO official said the organization's scientists would revisit Gibbs's theory once it emerged in the scientific literature.
::::::::
Dr. Adrian Gibbs, Australian Virologist, on Bloomberg TV
PETER'S NEW YORK, Tuesday, November 24, 2009--A just-released scientific paper spells out the hypothesis, first suggested in the weeks following the initial outbreak of swine flu in humans in the Spring of 2009, that the flu emerged from a laboratory.
The peer-reviewed paper, published today in the Journal of Virology, analyzes the makeup of the genes of the now-famous A H1N1 virus, and concludes that, although it could possibly have come about through cross-contamination among flocks of birds or herds of swine, an equally, or perhaps more probable explanation is that it emerged from laboratories that store viruses for research or vaccine production.
The authors, Adrian J. Gibbs, John S. Armstrong and Jean C. Downie, contend they have identified three swine flu viruses as the most likely parents of the new flu. The last time these parent viruses were known to have caused disease in pigs was from ten to seventeen years ago. Each parent comes from a different continent--one from North America, another from Europe, and a third from Asia. In order for these parent viruses to have combined in nature to form the new virus, pigs would need to have breached strict quarantines designed to prevent the spread of livestock disease. But the scientists note that the European parent was never found in North America, nor the North American virus in Europe, indicating that the quarantines were effective. This, of course, begs the question of how the parent viruses got together to form the new virus.
Some scientists have suggested that the pigs were shipped internationally and violated the strict quarantines. But Gibbs and his colleagues say perhaps a more credible hypothesis is that the parent viruses were individually stored in different sections of a laboratory, or in different laboratories, and were brought together for research or in the production of a vaccine. Storage in a laboratory would also explain why the parent viruses remained undetected in pig populations for a decade or more, and then suddenly emerged as components of the new virus--they were sitting on a shelf in a laboratory refrigerator during the interim. "Viruses," the paper notes, "do travel between laboratories in cells." The authors say additional investigative work is needed to establish which scenario is most likely.
"The possibility that human activity may have had some role in its (the swine flu virus) origins should not be dismissed without a dispassionate analysis of all available evidence," the paper states.
The escape of a disease-causing virus from a laboratory would not be an unprecedented event, the authors contend. They note that a virus that had not been sampled since the 1950s and one that emerged in 1977 were practically identical. Had the virus been infecting humans in the interim, it would have mutated. The absence of mutations suggests that the virus had been sitting in a laboratory refrigerator during the time its presence in humans went undetected.
The best ways to trace the origins of the new swine flu, according to Gibbs's team, is by maintaining a database of viruses and viral components from laboratories around the world, and by instituting more intense monitoring of infected animal and human populations.
The swine flu virus "has already proved to be a significant and very costly cause of mortality and morbidity in the human population," the authors note. "It is important that the source of the new virus be found if we wish to avoid future pandemics rather than just trying to minimize the consequences after they have emerged."
Gibbs, lead author of the paper, achieved notoriety in May of 2009 when he was among the first in the scientific community to suggest that the virus causing the swine flu showed telltale signs of having been produced in a laboratory. Gibbs, who has some 200 scientific publications to his credit, became a familiar icon on TV screens across the globe after being interviewed about his theory by reporters and talking heads from major media outlets. The Australian professor and researcher relayed his concerns to officials at the Geneva-Switzerland-based World Health Organization (WHO), where scientists examined, but tentatively rejected, his hypothesis. A WHO official said the organization's scientists would revisit Gibbs's theory once it emerged in the scientific literature.
Wednesday, 28 October 2009
Swine Flu Special Alert
An interview between Dr. Mercola and Barbara Loe Fisher. This interview was originally posted with an article, to view the article in question visit: Here
Monday, 26 October 2009
US declares swine flu 'emergency'
US President Barack Obama has declared swine flu a national emergency.
The White House said the president signed the proclamation concerning the 2009 H1N1 outbreak on Friday evening.
It increases the ability of treatment facilities to handle a surge in H1N1 patients by easing the implementation of emergency plans.
Last week US officials said swine flu activity was widespread in 46 states. More than 1,000 US deaths have been linked to the virus.
Health officials say the infections are already comparable to peak season flu levels.
Vaccine warning
US officials said the president's declaration was similar to ones issued before hurricanes make landfall.
It allows authorities to bypass certain federal requirements in order to deal more effectively with emergencies.
The aim of the directive is to remove bureaucratic hurdles, allowing sick patients to receive treatment more quickly and giving health-care providers more flexibility in providing it.
Paperwork on patients can be reduced and additional health centres set up outside hospitals to care for the sick.
In his proclamation statement, Mr Obama says the 2009 H1N1 pandemic "continues to evolve".
"The rates of illness continue to rise rapidly within many communities across the nation, and the potential exists for the pandemic to overburden health care resources in some localities."
He said the US had already taken "proactive steps" by implementing public health measures and developing an effective swine flu vaccine.
However, the government has admitted there are delays in the delivery of vaccines.
It had hoped to roll out 120 million doses by mid-October.
It now hopes for about 50 million by mid-November and 150 million in December.
Dr Thomas Frieden, of the US Centers for Disease Control and Prevention (CDC), said on Friday: "We are nowhere near where we thought we'd be by now."
Given the shortfall, New York State on Friday stayed a directive ordering health care staff to be inoculated or risk losing their jobs.
The CDC says widespread influenza activity in 46 states is "unprecedented during seasonal flu".
It said the hospitalisation rates for laboratory-confirmed swine flu were still climbing.
Although figures are hard to verify, it is thought H1N1 has hospitalised about 20,000 people in the US.
Visits to the doctor for influenza-like illnesses were also much higher than expected for the time of year, the CDC said.
The seasonal flu peak is usually between late November and early March.
Children and young adults have been among the hardest hit by H1N1. Almost 100 of the deaths have been children.
Original article from BBC
The White House said the president signed the proclamation concerning the 2009 H1N1 outbreak on Friday evening.
It increases the ability of treatment facilities to handle a surge in H1N1 patients by easing the implementation of emergency plans.
Last week US officials said swine flu activity was widespread in 46 states. More than 1,000 US deaths have been linked to the virus.
Health officials say the infections are already comparable to peak season flu levels.
Vaccine warning
US officials said the president's declaration was similar to ones issued before hurricanes make landfall.
It allows authorities to bypass certain federal requirements in order to deal more effectively with emergencies.
The aim of the directive is to remove bureaucratic hurdles, allowing sick patients to receive treatment more quickly and giving health-care providers more flexibility in providing it.
Paperwork on patients can be reduced and additional health centres set up outside hospitals to care for the sick.
In his proclamation statement, Mr Obama says the 2009 H1N1 pandemic "continues to evolve".
"The rates of illness continue to rise rapidly within many communities across the nation, and the potential exists for the pandemic to overburden health care resources in some localities."
He said the US had already taken "proactive steps" by implementing public health measures and developing an effective swine flu vaccine.
However, the government has admitted there are delays in the delivery of vaccines.
It had hoped to roll out 120 million doses by mid-October.
It now hopes for about 50 million by mid-November and 150 million in December.
Dr Thomas Frieden, of the US Centers for Disease Control and Prevention (CDC), said on Friday: "We are nowhere near where we thought we'd be by now."
Given the shortfall, New York State on Friday stayed a directive ordering health care staff to be inoculated or risk losing their jobs.
The CDC says widespread influenza activity in 46 states is "unprecedented during seasonal flu".
It said the hospitalisation rates for laboratory-confirmed swine flu were still climbing.
Although figures are hard to verify, it is thought H1N1 has hospitalised about 20,000 people in the US.
Visits to the doctor for influenza-like illnesses were also much higher than expected for the time of year, the CDC said.
The seasonal flu peak is usually between late November and early March.
Children and young adults have been among the hardest hit by H1N1. Almost 100 of the deaths have been children.
Original article from BBC
Friday, 16 October 2009
U.S. Army uncovers successful results for AIDS vaccine
Snippet: "BAGRAM AIR FIELD, Afghanistan – The fight against one of the deadliest virus known may have met its match against the United States Army. The Army in conjunction with the Thai Ministry of Public Health, the National Institute of Allergy and Infectious Disease, the National Institutes of Health, Sanofi Pasteur and Global Solutions for Infectious Diseases have uncovered successful results for an AIDS vaccination." |
To view the full article visit: Combined Joint Task Force
Thursday, 15 October 2009
A One-in-a-Million Shot
Snippet: "ASHBURN, Va. -- Desiree Jennings thought it would be a good idea to get the seasonal flu shot. Her job offered incentives for it, and she didn't want to get sick. Ten days after she got the shot at a Reston Safeway, she did get sick. "I got flu-like symptoms -- nausea, vomiting, body aches, fever -- then was lethargic for a week and started blacking out," said Jennings, an AOL employee and Washington Redskins ambassador hoping to one day be a cheerleader for the team, the Loudoun Times-Mirror reported." |
To view the complete article visit: NBC Washington
Saturday, 10 October 2009
Wednesday, 7 October 2009
H1N1 Swine Flu Vaccine Nasal Spray Contents
Warning: Under no circumstances should this be used by pregnant women.
Each pre-filled refrigerated FluMist sprayer contains a single 0.2 mL dose.
Each 0.2 mL dose contains:
*106.5-7.5 FFU of live attenuated influenza virus reassortants of each of the three strains:
A/South Dakota/6/2007 (H1N1) (an A/Brisbane/59/2007-like), A/Uruguay/716/2007 (H3N2) (an
A/Brisbane/10/2007-like), and B/Brisbane/60/2008 [1].
*0.188 mg/dose monosodium glutamate (MSG): C5H8NNaO4, a Stabilizer MSG - MSG intolerance: There have been numerous studies of allergies and/or sensitivities to MSG, attributed to the free glutamic acid component, which has been blamed for causing a wide variety of physical symptoms such as migraines, nausea, digestive upsets, drowsiness, heart palpitation, hair loss, asthma, anaphylactic shock, rapidly increasing diabetes, and many other complaints.
*2.00 mg/dose hydrolyzed porcine gelatin: Pig skin based gelatine
*2.42 mg/dose arginine: amino acid
*13.68 mg/dose sucrose: table sugar, a disaccharide of glucose and fructose
*2.26 mg/dose dibasic potassium phosphate: the dipotassium salt, K2HPO4; used alone or in combination with other phosphate compounds as an electrolyte replenisher
*0.96 mg/dose monobasic potassium phosphate: the monopotassium salt, KH2PO4; used as a buffering agent in pharmaceutical preparations and, alone or in combination with other phosphate compounds, as an electrolyte replenisher, urinary acidifier, and antiurolithic
*<0.015 mcg/mL gentamicin sulfate: A broad-spectrum antibiotic derived from an actinomycete used in the treatment of various infections
FluMist contains no preservatives.
Each pre-filled refrigerated FluMist sprayer contains a single 0.2 mL dose.
Each 0.2 mL dose contains:
*106.5-7.5 FFU of live attenuated influenza virus reassortants of each of the three strains:
A/South Dakota/6/2007 (H1N1) (an A/Brisbane/59/2007-like), A/Uruguay/716/2007 (H3N2) (an
A/Brisbane/10/2007-like), and B/Brisbane/60/2008 [1].
*0.188 mg/dose monosodium glutamate (MSG): C5H8NNaO4, a Stabilizer MSG - MSG intolerance: There have been numerous studies of allergies and/or sensitivities to MSG, attributed to the free glutamic acid component, which has been blamed for causing a wide variety of physical symptoms such as migraines, nausea, digestive upsets, drowsiness, heart palpitation, hair loss, asthma, anaphylactic shock, rapidly increasing diabetes, and many other complaints.
*2.00 mg/dose hydrolyzed porcine gelatin: Pig skin based gelatine
*2.42 mg/dose arginine: amino acid
*13.68 mg/dose sucrose: table sugar, a disaccharide of glucose and fructose
*2.26 mg/dose dibasic potassium phosphate: the dipotassium salt, K2HPO4; used alone or in combination with other phosphate compounds as an electrolyte replenisher
*0.96 mg/dose monobasic potassium phosphate: the monopotassium salt, KH2PO4; used as a buffering agent in pharmaceutical preparations and, alone or in combination with other phosphate compounds, as an electrolyte replenisher, urinary acidifier, and antiurolithic
*<0.015 mcg/mL gentamicin sulfate: A broad-spectrum antibiotic derived from an actinomycete used in the treatment of various infections
FluMist contains no preservatives.
Tuesday, 6 October 2009
H1N1 Swine Flu Vaccine Facts to Consider
In order to make informed vaccine decisions, you must know what the ingredients are in the vaccine. There are no long-term safety studies done on any vaccines, including the flu vaccines. This new flu vaccine will be released without adequate safety studies.
Common Flu Vaccine Ingredients include:
* Egg protein, many are allergic to eggs
* Formaldehyde - Formalyn (formalin) is a 37 percent solution of gaseous formaldehyde which includes methanol. (Used in vaccines as a tissue fixative) Formaldehyde solution (formalin) is considered a hazardous compound and it is vapor toxic.
* Polysorbate 80 shown to cause infertility in mice
* Sodium Chloride and Calcium Chloride
* Monosodium Glutamate (MSG):C5H8NNaO4, a Stabilizer MSG - MSG intolerance: There have been numerous studies of allergies and/or sensitivities to MSG, attributed to the free glutamic acid component, which has been blamed for causing a wide variety of physical symptoms such as migraines, nausea, digestive upsets, drowsiness, heart palpitation, hair loss, asthma, anaphylactic shock, rapidly increasing diabetes, and many other complaints.
* Potassium phosphate- a soluble salt which is used as a fertilizer, a food additive and a fungicide. It is a source of phosphorus and potassium. It is also a buffering agent.
* Thimerosal- a form of mercury still found in some multi-vile vaccines.
* Polyoxidonium- Synthetic polymers and nanomaterials display selective phenotypic effects in cells and in the body that affect signal transduction mechanisms involved in inflammation, differentiation, proliferation, and apoptosis. When physically mixed or covalently conjugated with cytotoxic agents, bacterial DNA or antigens, polymers can drastically alter specific genetically controlled responses to these agents.
* Squalene - An oil based adjuvant that has never been approved in the US as safe, can cause blindness, autoimmune dysfunction and can inhibit sperm production. More than two dozen peer-reviewed scientific papers from ten different laboratories throughout the U.S., Europe, Asia, and Australia have been published documenting the development of autoimmune disease in animals subjected to squalene-based adjuvants. Novartis will make a flu vaccine using MF59 consisting of Squalene, Tween 80 - A recent study (December 2005) discovered that Tween80 can cause anaphylaxis, a sometimes fatal reaction characterized by a sharp drop in blood pressure, hives, and breathing difficulties.
* Span85 another oil
* Human Diploid Tissue - organ and tissue from aborted baby tissue is now used in manufacturing many vaccines.
* H1N1 virus - Split virus (inactive)
Common Flu Vaccine Ingredients include:
* Egg protein, many are allergic to eggs
* Formaldehyde - Formalyn (formalin) is a 37 percent solution of gaseous formaldehyde which includes methanol. (Used in vaccines as a tissue fixative) Formaldehyde solution (formalin) is considered a hazardous compound and it is vapor toxic.
* Polysorbate 80 shown to cause infertility in mice
* Sodium Chloride and Calcium Chloride
* Monosodium Glutamate (MSG):C5H8NNaO4, a Stabilizer MSG - MSG intolerance: There have been numerous studies of allergies and/or sensitivities to MSG, attributed to the free glutamic acid component, which has been blamed for causing a wide variety of physical symptoms such as migraines, nausea, digestive upsets, drowsiness, heart palpitation, hair loss, asthma, anaphylactic shock, rapidly increasing diabetes, and many other complaints.
* Potassium phosphate- a soluble salt which is used as a fertilizer, a food additive and a fungicide. It is a source of phosphorus and potassium. It is also a buffering agent.
* Thimerosal- a form of mercury still found in some multi-vile vaccines.
* Polyoxidonium- Synthetic polymers and nanomaterials display selective phenotypic effects in cells and in the body that affect signal transduction mechanisms involved in inflammation, differentiation, proliferation, and apoptosis. When physically mixed or covalently conjugated with cytotoxic agents, bacterial DNA or antigens, polymers can drastically alter specific genetically controlled responses to these agents.
* Squalene - An oil based adjuvant that has never been approved in the US as safe, can cause blindness, autoimmune dysfunction and can inhibit sperm production. More than two dozen peer-reviewed scientific papers from ten different laboratories throughout the U.S., Europe, Asia, and Australia have been published documenting the development of autoimmune disease in animals subjected to squalene-based adjuvants. Novartis will make a flu vaccine using MF59 consisting of Squalene, Tween 80 - A recent study (December 2005) discovered that Tween80 can cause anaphylaxis, a sometimes fatal reaction characterized by a sharp drop in blood pressure, hives, and breathing difficulties.
* Span85 another oil
* Human Diploid Tissue - organ and tissue from aborted baby tissue is now used in manufacturing many vaccines.
* H1N1 virus - Split virus (inactive)
Subscribe to:
Posts (Atom)
